Elevated levels of α-dicarbonyl compounds in the plasma of type II diabetics and their relevance with diabetic nephropathy

• Published in: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences Analytical technologies in the biomedical and life sciences, 2019-02, Vol.1106-1107, p.19-25
• Main Authors: Wang, Xin-Jie, Ma, Sheng-Bo, Liu, Zhuo-Feng, Li, Heng, Gao, Wen-Yun
• Format: Article
• Language: English
• Subjects: Blood plasma; Diabetic nephropathy; Type 2 diabetes mellitus; α-Dicarbonyl compounds
• ISSN: 1570-0232; 1873-376X
• DOI: 10.1016/j.jchromb.2018.12.027

The presence of α‑dicarbonyl compounds (α-DCs) in vivo has been associated with the development of complications of diabetes mellitus (DM) and also with other chronic diseases. Therefore, quantitative analysis of α-DCs in body fluids is crucial to understand their roles in the formation of these chronic diseases. We established in this study a practical HPLC-UV method to measure 3‑deoxyglucosone (3-DG), glyoxal (GO), methylglyoxal (MGO), diacetyl (DA), and pentane‑2,3‑dione (PD) in blood plasma using 4‑(2,3‑dimethyl‑6‑quinoxalinyl)‑1,2‑benzenediamine (DQB) as a derivatizing reagent. The derivatizing reaction could be carried out quickly under mild conditions and the HPLC determination is simple, sensitive, and easy to operate. The recoveries of the α-DCs are between 85.26% and 110.20% (intra-day) and 87.25% and 103.18% (inter-day); the RSDs are between 1.28% and 5.69% (intra-day) and 2.26% and 6.34% (inter-day). We found the plasma levels of 3-DG, GO, and MGO in the diabetic patients are all significantly higher than those in healthy subjects. The results also show that the contents of GO and MGO in diabetic nephropathy (DN) patients are both significantly higher than those in simple T2DM patients. Moreover, it is found for the first time that the plasma level of GO might be a potential predictor of DN. The developed method would be useful for the measurements of the plasma α-DCs and the data acquired could be informative in the diagnosis of DM complications. •A novel HPLC method for analyzing α-DCs in plasma has been developed.•Respective correlations of plasma 3-DG, Gly, and MGly with HbA1c and fasting glucose are observed.•Correlation between plasma Gly and diabetic nephropathy is setup for the first time.